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Mammalian selenocysteine-containing proteins charac-
terized with respect to function are involved in redox pro-
cesses and exhibit distinct expression patterns and cellular
locations. A recently identified 15-kDa selenoprotein
(Sep15) has no homology to previously characterized pro-
teins, and its function is not known. Here we report the
intracellular localization and identification of a binding
partner for this selenoprotein which implicate Sep15 in the
regulation of protein folding. The native Sep15 isolated
from rat prostate and mouse liver occurred in a complex
with a 150-kDa protein. The latter protein was identified as
UDP-glucose:glycoprotein glucosyltransferase (UGTR), the
endoplasmic reticulum (ER)-resident protein, which was
previously shown to be involved in the quality control of
protein folding. UGTR functions by glucosylating misfolded
proteins, retaining them in the ER until they are correctly
folded or transferring them to degradation pathways. To
determine the intracellular localization of Sep15, we ex-
pressed a green fluorescent protein-Sep15 fusion protein in
CV-1 cells, and this protein was localized to the ER and
possibly other perinuclear compartments. We determined
that Sep15 contained the N-terminal signal peptide that
was essential for translocation and that it was cleaved in
the mature protein. However, C-terminal sequences of
Sep15 were not involved in trafficking and retention of
Sep15. The data suggest that the association between Sep15
and UGTR is responsible for maintaining the selenoprotein
in the ER. This report provides the first example of the
ER-resident selenoprotein and suggests a possible role of
the trace element selenium in the quality control of protein
folding.
Selenium is an essential trace element in the diet of many or-
ganisms, including humans. It is present in the form of a seleno-
cysteine (Sec)1 residue in several naturally occurring enzymes and
proteins (1, 2). In selenoenzymes with established function, such as
glutathione peroxidases, thyroid hormone deiodinases, and thiore-
doxin reductases in mammals, and hydrogenases and formate de-
hydrogenases in bacteria and archaea, Sec is present at the enzyme
active center and participates in various redox reactions (2).
Functions of many other mammalian selenoproteins, includ-
ing the 15-kDa selenoprotein (Sep15), selenoprotein P, seleno-
protein W, selenoprotein R (also named selenoprotein X), sel-
enoprotein T, and selenoprotein N, have not been established.
However, most of these proteins have clearly identifiable Sec-
containing redox motifs, such as the Cys-Xaa-Xaa-Sec motif in
selenoprotein W and selenoprotein T, suggesting their possible
involvement in redox processes (3).
Sep15 was recently identified in human T-cells (4). The gene for
this protein is expressed in various human tissues with highest
expression levels in the prostate and thyroid. In addition to hu-
mans, genes encoding Sep15 were detected in mice and rats. Sep15
exhibits no homology to previously characterized proteins, which
precluded its functional characterization. However, Sep15 has a
highly conserved motif, Cys-Gly-Sec-Lys, suggesting that this cen-
ter could constitute an active center, in which Sec and Cys form a
reversible seleno-sulfide bond. Besides this putative redox center, a
previously noted feature in the Sep15 sequence was the lack of
N-terminal sequences in the isolated human T-cell selenoprotein,
which suggested the possibility of post-translational processing of
the protein. In addition, Sep15 migrated as the 15-kDa protein on
SDS-PAGE gels, whereas the migration properties of the native
protein were consistent with a protein of ;160–240 kDa. The low
abundance of the 15-kDa selenoprotein in human T-cells and its
lability during isolation did not permit isolation of the native pro-
tein to homogeneity to test whether the 160-kDa complex was
composed of multiple selenoprotein subunits or if other protein
components were involved in the complex (4).
The finding that the protein was expressed in the prostate at
elevated levels compared with other tissues (4, 5) provided an
opportunity to determine the oligomeric composition of Sep15 by
isolating the selenoprotein from this organ. In this report, we de-
scribe isolation of Sep15 from rat prostate and mouse liver. In both
preparations, the native selenoprotein occurred as a complex with
UDP-glucose:glycoprotein glucosyltransferase (UGTR), an enzyme
involved in the quality control of protein folding (6). Further char-
acterization revealed that Sep15 was located in perinuclear cellular
compartments, consistent with the finding that UGTR is located in
the endoplasmic reticulum (ER). The observation that Sep15 was
found only in a complex with UGTR suggests that it may be in-
volved in the regulation of protein folding.
EXPERIMENTAL PROCEDURES
Materials—Rat prostate and mouse liver were purchased from Pel-
Freez. [75Se]Selenious acid (specific activity 1,000 Ci/mmol) was from
the University of Missouri Research Reactor Facility (Columbia, MO).
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Phenyl-TSK and DEAE-TSK HPLC columns were from TosoHaas. The
phenyl-Superose FPLC column, Q-Sepharose, and ConA-Sepharose
were from Amersham Pharmacia Biotech. LipofectAMINE was from
Life Technologies, Inc. Polyclonal anti-green fluorescent protein (GFP)
antibodies were from Invitrogen. Escherichia coli strain NovaBlue was
from Novagen. The Maxi kit for plasmid isolation was from Qiagen,
BODIPY®TR ceramide was from Molecular Probes, native and SDS-
PAGE gels and immunoblot membranes were from Novex, and immu-
noblot detection systems ECL-Plus and SuperSignal were from Amer-
sham Pharmacia Biotech and Pierce, respectively. Other reagents were
of the highest quality available.
75Se Labeling of the 15-kDa Protein—Rat cell line RLE was grown on
RPMI 1640 medium for 48 h in the presence of 0.5 mCi of sodium
[75Se]selenite/100 ml of cell culture medium. Cells were washed four
times with phosphate-buffered saline, collected by trypsinization, and
stored at 280 °C prior to use. 75Se-Labeled mouse liver was obtained as
described (7). Briefly, 0.5 mCi of freshly neutralized [75Se]selenious acid
was injected intraperitoneally, the mouse was sacrificed 48 h later, and
75Se-labeled tissues were collected and stored at 280 °C prior to use.
Isolation of Sep15 from Rat Prostate—133 g of rat prostate was mixed
with 75Se-labeled rat RLE cells and homogenized at 4 °C in 400 ml of 20
mM Tris-HCl, pH 7.5, containing 1 mM EDTA, 1 mM AEBSF, 1 mM DTT,
5 mg/ml leupeptin, and 5 mg/ml aprotinin, and the homogenate was
further treated by sonication. Insoluble material was removed by cen-
trifugation, and the supernatant was applied to a 200-ml Q-Sepharose
column equilibrated with 20 mM Tris-HCl, pH 7.5, containing 1 mM
EDTA and 1 mM DTT (buffer A). After washing the column with 2
volumes of buffer A, the bound proteins were eluted by application of a
linear gradient from buffer A to 1 M NaCl in buffer A. 75Se was deter-
mined with a g-counter, and column fractions containing peaks of
radioactivity were analyzed by SDS-PAGE followed by detection of 75Se
on gels with a PhosphorImager. Fractions containing the 75Se-labeled
Sep15 were identified based on migration properties of this protein on
SDS-PAGE, combined, concentrated, made in 1 M NaCl, filtered, and
applied to a phenyl-HPLC column equilibrated in 1 M NaCl in buffer A.
The protein was eluted by application of a linear gradient from 1 M NaCl
in buffer A to buffer A, and the column was washed further with a short
gradient from buffer A to water, which eluted Sep15. Fractions contain-
ing 75Se were analyzed by SDS-PAGE followed by the PhosphorImager
analysis as described above. Fractions containing Sep15 were then
applied directly to a DEAE-HPLC column equilibrated in buffer A.
Sep15 was eluted with a gradient from buffer A to 0.5 M NaCl in buffer
A. Radioactive fractions were concentrated and stored at 280 °C until
ready for use.
Gel Electrophoretic Analyses of the Rat Prostate 15-kDa Selenopro-
tein—Fractions containing Sep15 were analyzed on native and SDS-
PAGE gels. To determine if the ;160-kDa protein band, which ap-
peared on native gels and was labeled with 75Se, contained Sep15 and
UGTR, a native PAGE gel was briefly stained with Coomassie Blue, the
band of interest cut from the gel, minced, incubated overnight in SDS-
PAGE sample buffer containing 10 mM DTT, and the liquid fraction
analyzed by SDS-PAGE. The 150-kDa protein band, which appeared on
an SDS-PAGE gel after staining with Ponceau S, was used for the
subsequent sequence analysis.
Tryptic Peptide Analysis of the 150-kDa Protein Band—A gel slice
containing a Ponceau S-stained 150-kDa protein band was sent to
Harvard Microchem (Boston) where the protein was digested with
trypsin, and the resulting peptides were separated by reverse phase
chromatography and their masses determined by electrospray mass
spectrometry. Four tryptic peptides were sequenced by Edman degra-
dation comprising a total of 88 amino acid residues.
Isolation of the 15-kDa Selenoprotein from Mouse Liver—Initial frac-
tionations of mouse liver Sep15 and UGTR were carried out as de-
scribed for rat prostate. Subsequent isolations took advantage of the
fact that UGTR could be isolated efficiently by affinity chromatography
on a ConA-Sepharose resin. 150 g of mouse liver was mixed with 3 g of
75Se-labeled mouse liver and homogenized at 4 °C in 3 volumes of buffer
A containing 0.5 mM sodium orthovanadate and protease inhibitors
used in the rat prostate fractionation. The homogenate was sonicated,
clarified by centrifugation, and the clear supernatant was applied to a
Q-Sepharose column equilibrated with buffer A. The bound proteins
were eluted using a linear 0–1.5 M gradient of NaCl in buffer A.
Fractions were analyzed for the presence of 75Se-labeled proteins as
described for rat prostate. The fractions containing labeled Sep15 were
combined, concentrated, and applied to a ConA-Sepharose column that
was equilibrated with 20 mM Tris-HCl, pH 7.4, containing 0.5 M NaCl
(buffer B). The column was washed with buffer B, and proteins were
eluted by the application of a step gradient of 10, 50, 100, 200, and 300
mM methyl a-D-mannopyranoside in buffer B. Fractions containing
75Se-labeled Sep15 were pooled, concentrated, and applied to a phenyl-
HPLC column as described for rat prostate. The protein was eluted in
two overlapping peaks, the first peak containing both UGTR and Sep15,
and the second peak containing only UGTR. Fractions containing Sep15
were pooled and subsequently applied onto a DEAE-HPLC column as
described above. Proteins eluted from the DEAE column were analyzed
by native and SDS-PAGE and by immunoblot assays with antibodies
specific for Sep15 or UGTR.
Constructs with GFP—N-Sep15-C-GFP denotes the following: N is
the 28-residue N-terminal signal peptide of Sep15; Sep15 is the 15-kDa
selenoprotein without its signal peptide and 4 C-terminal residues; C is
the C-terminal tetrapeptide of Sep15; and GFP is the 239-residue GFP.
N-Sep15-C-GFP and Sep15-C-GFP constructs were made using the
pEGFP-N1 expression vector. Human Sep15 cDNA (U93C), in which
the Sec codon, TGA, was mutated to a cysteine codon, TGC, was am-
plified with primers T7 and XhoI-15-1h (59-CCACTCGAGGCGTTC-
CAACTTTTCACT-39) and designated N-Sep15-C-GFP. U93C amplified
with primers Sal-15-1h (59-CGCAACGTCGACATGTCTGCTTTT-
GGGGCAGAG-39) and XhoI-15-1h was designated Sep15-C-GFP. The
resulting polymerase chain reaction products were cloned into the XhoI
site of pEGFP-N1. The GFP-Sep15-C construct was made using the
pEGFP-C3 expression vector. Human Sep15 mutant cDNA, U93C, was
amplified with primers Sal-15-1h and T3 and cloned into the XhoI/
Bsp120I sites of pEGFP-C3. The fragment encoding N-terminal se-
quences of the 15-kDa protein was obtained by amplification of the
U93C cDNA with primers T7-NheI, 59-CGATGCTAGCTAATACGACT-
CACTATAGGG-39, and AgeI-15-1h, 59-CACGACCGGTGCCTCCGAT-
GAAAACTCTGCC-39. N-GFP-Sep15-C and N-GFP constructs were
made by cloning this fragment into the NheI/AgeI sites of GFP-Sep15-C
and pEGFP-N1, respectively. The N-GFP-Sep15 construct was obtained
by mutagenesis of N-GFP-Sep15-C with primers 15-1h-159stopF, 59-
CCTGAGTGAAAAGTAGGAACGCATATAAATCTTGC-39 and 15-1h-
159stopR, 59-GCAAGATTTATATGCGTTCCTACTTTTCACTCAGG-39.
All constructs were transformed into the E. coli strain NovaBlue, and
the plasmids were isolated using a Maxi kit.
Immunoblot Analyses—Immunoblot assays with rabbit polyclonal
antibodies raised against UGTR isolated from rat liver (8) and against
the keyhole limpet hemocyanin-conjugated synthetic peptide corre-
sponding to the C-terminal portion of Sep15 (4) were performed using
the ECL-Plus detection system. Rabbit polyclonal antibodies specific for
GFP were used for the detection of GFP-Sep15 fusion proteins with an
ECL system.
Cell Growth, Transfection, and Dual Fluorescence Imaging Confocal
Microscopy—Growth of monkey CV-1 cells and transfection were car-
ried out as described (9). 5 mg of plasmid DNA and 30 ml of
LipofectAMINE were used for transfection of each 60-mm plate. CV-1
cells transfected with the appropriate constructs were incubated for
12 h in a CO2 incubator. We used a fluorescent BODIPY®TR ceramide
as a reference marker for perinuclear structures. This reagent has been
shown to be accumulated in the ER and Golgi and has been used to
study protein trafficking (10, 11). The transfected cells were rinsed with
serum-free Dulbecco’s modified Eagle’s medium containing 10 mM
HEPES (DMEM-HEPES) and then incubated for 25 min at room tem-
perature in the same medium containing 2 mM BODIPY®TR ceramide.
The cells were washed twice in serum-free DMEM-HEPES and were
used immediately for image collection. Double-labeled images of live
cells were collected with a water immersion lens using a dual excitation/
emission and dual channel mode on a Bio-Rad MRC1024ES laser-
scanning microscope.
RESULTS
Native Rat Prostate Sep15 Is Composed of Multiple Polypep-
tides—Sep15 was previously isolated from a human T-cell line,
but small amounts of isolated proteins and protein lability
precluded molecular characterization of native Sep15 (4). Sub-
sequent studies found that the protein is expressed at higher
levels in the prostate (4, 5). In the present study, a procedure
for isolation of Sep15 from rat prostate was developed which
included fractionation of protein extracts on conventional Q-
Sepharose and phenyl-HPLC columns followed by an HPLC
procedure on a DEAE column. To allow efficient detection of
Sep15 in chromatographic fractions by tracing g-radioactivity,
rat prostate homogenates were mixed with the 75Se-labeled
extracts obtained from a rat cell line, and the combined extract
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was used for further isolation. Immunoblot and PhosphorIm-
ager detection of Sep15 on gradient nondenaturing and SDS-
denaturing PAGE gels in fractions from the first two columns
revealed that the native protein migrated as a large, ;165-
kDa, species. However, these same fractions migrated as the
15-kDa species on SDS-PAGE gels (data not shown). Although
native gradient PAGE does not accurately determine the mo-
lecular weight of a protein, an 11-fold difference in masses
between denaturing and nondenaturing conditions suggested
that the native Sep15 was bound to another protein or proteins
in the rat prostate or was composed of multiple identical sel-
enoprotein subunits. These data were also consistent with the
previous electrophoretic and gel filtration experiments of par-
tially purified human T-cell Sep15 (4).
Native Rat Prostate Sep15 Is Associated with the 150-kDa
Protein—Electrophoresis of the protein preparation isolated by
the three purification steps described above is shown in Fig. 1.
Native gel electrophoresis revealed a Coomassie Blue-stained
band of ;165 kDa (Fig. 1A, lane 3). This band contained Sep15
as it was labeled with 75Se and was immunoreactive with
anti-Sep15 antibodies (data not shown). SDS-PAGE analysis of
the 165-kDa band showed that it consisted of a 150-kDa protein
and Sep15 (Fig. 1B, lane 2). It was noted that the 150-kDa
protein was also present in a selenoprotein-free form (Fig. 1A,
lane 2) which eluted later than the 150-kDa protein-Sep15
complex from a phenyl-HPLC column. In contrast, we were not
able to detect Sep15 that was free of the 150-kDa protein in rat
prostate fractions.
The 150-kDa Protein Is UGTR—The 150-kDa protein was
digested with trypsin, and the sequence of four peptides con-
sisting of a total of 88 amino acid residues was determined (Fig.
2). Two of these peptides were not homologous to any known
sequences, but the other two showed partial sequence homol-
ogy with Drosophila melanogaster UGTR (GenBank accession
number U20554) (12). During these initial studies, no mamma-
lian UGTR sequences were available in GenBank. However, all
four 150-kDa protein peptides were identical with internal
peptides of the rat liver UGTR sequence that was deduced from
the corresponding cDNA sequence (kindly provided by Dr. A.
Parodi). In addition, several mammalian UGTR sequences sub-
sequently became available in GenBank, including rat UGTR
(accession number AF200359) (13) and two human UGTRs
(accession numbers AF227905 and AF227906) (14). Sequences
of internal peptides obtained from the 150-kDa protein were
identical with the internal sequences of the rat protein and
were highly homologous with the human sequences. This fur-
ther confirmed that the 150-kDa protein is UGTR. The relative
locations of the four peptide sequences within rat liver UGTR
are shown in Fig. 2B. UGTR has been shown to be responsible
for the quality control of protein folding in yeast and verte-
brates (6). This protein is located in the ER and functions by
reglucosylating misfolded proteins in the ER lumen, thus al-
lowing them to interact with calnexin/calreticulin chaperones
(15, 16).
UGTR and Sep15 were also detected by Western analysis in
fractions from a phenyl-HPLC column (Fig. 3). UGTR eluted in
two overlapping peaks, the first of which contained Sep15 (Fig.
1A, lane 3; Fig. 3, lanes 1, 3, 5, and 7), whereas the second peak
did not contain the selenoprotein (Fig. 1A, lane 2; Fig. 3, lanes
2, 4, 6, and 8). The proteins shown in Fig. 3 were separated by
SDS-PAGE in the presence (Fig. 3, lanes 1 and 2, and 5 and 6)
and absence (Fig. 3, lanes 2–4, and 7 and 8) of a reducing agent
DTT, which did not influence mobility of UGTR and Sep15 on
SDS-PAGE. This suggests that the isolated UGTRzSep15 com-
plex did not contain a significant amount of interprotein disul-
fide bonds.
Association between the 15-kDa Protein and UGTR in Mouse
Liver—To determine whether the association between Sep15
and UGTR is a general phenomenon rather than a cell type-
specific event, we fractionated mouse liver extracts and tested
elution patterns of these two proteins (Figs. 4 and 5). Initially,
75Se-labeled liver homogenates were fractionated on DEAE
and phenyl columns, and protein fractions were analyzed for
the presence of UGTR by immunoblot assays and for the pres-
ence of Sep15 by detection of 75Se with a PhosphorImager.
These assays revealed that UGTR and Sep15 coeluted from
these columns (Fig. 4). We further attempted isolation of UGTR
to near homogeneity and tested whether isolated UGTR con-
tained Sep15. For this purpose, we utilized a ConA column,
which is an affinity column used previously in the purification
of UGTR (8) as an additional intermediate step. The apparently
homogeneous preparation of UGTR was then analyzed by im-
munoblot assays for the presence of Sep15. Analyses of five
subsequent fractions from the phenyl column in the procedure
that employed the ConA column are shown in Fig. 5. Detection
of proteins on native (Fig. 5A) and SDS-PAGE (Fig. 5B) gels
with antibodies specific for rat liver UGTR, as well as the use
of antibodies specific for Sep15 on native (Fig. 5C) and SDS-
FIG. 1. Gel electrophoretic analysis of the UGTRzSep15 com-
plex. Rat prostate extracts were fractionated sequentially using Q-
Sepharose, phenyl-HPLC, and DEAE-HPLC columns. Isolation of
Sep15 was followed by immunoblot assays. In A, Coomassie Blue stain-
ing of a native gradient PAGE gel is shown, and the lanes contain: 1,
protein standards; 2, 150-kDa band (UGTR); and 3, 165-kDa band (the
UGTRzSep15 complex). In B, Coomassie Blue staining of an SDS-PAGE
gel is shown, and the lanes contain: 1, protein standards (6–180-kDa
range); and 2, Sep15 preparation. The material for lane 2 was obtained
by excising a protein band similar to that shown in panel A, lane 3, from
the gel, soaking it overnight in SDS sample buffer in the presence of 10
mM DTT, and analyzing the extracted proteins by SDS-PAGE.
FIG. 2. Internal peptide sequences of rat prostate UGTR. In A,
amino acid sequences of four peptides obtained by tryptic digest of
isolated rat liver UGTR are shown. Residue numbers correspond to the
rat liver UGTR sequence. In B, the relative location of the four peptides
(filled boxes) within the putative UGTR from rat liver (long, rectangular
box) is shown. Other features shown within UGTR are the N-terminal
signal peptide (diagonal pattern) and the C-terminal ER retention
signal (horizontal pattern).
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PAGE (Fig. 5D) gels, suggested coelution of these proteins.
Overall, these data suggested that mouse liver preparations
contained Sep15 bound to UGTR. However, further studies are
required to address the quantitative relationship between the
UGTRzSep15 complex and the remaining cellular UGTR.
Intracellular Localization of the 15-kDa Protein—Because
UGTR exhibits specific intracellular localization (ER resident
protein) (17), we determined the cellular location of Sep15. For
this study, we employed a set of constructs that encoded vari-
ous fusion proteins between Sep15 and GFP (Fig. 6). These
constructs lacked a 39-untranslated region of Sep15 gene which
contains the Sec insertion sequence element (5). All known
eukaryotic selenoprotein genes, including Sep15, contain Sec
insertion sequence elements, which are stem-loop structures
located in 39-untranslated regions and are necessary to dictate
Sec insertion and prevent termination of protein synthesis at
in-frame UGA codons (1, 18). Accordingly, to express a full-size
polypeptide in the absence of the Sec insertion sequence ele-
ment, TGA that encodes Sec at position 93 in Sep15 was re-
placed in these constructs with TGC that encodes cysteine.
These mutations were made to increase translation efficiency
because efficiency of selenoprotein synthesis from transfected
constructs in mammalian cells is low (19). The constructs were
transiently transfected into monkey CV-1 cells, and confocal
microscopy was used to localize fusion proteins by detecting the
GFP green fluorescence (Fig. 7). To determine the location of
the transiently expressed proteins, we used a cell-permeable
fluorescent ceramide conjugate, which is known to label the ER
and Golgi (11, 20). In addition, expression of fusion proteins
and their experimental molecular masses was obtained by as-
saying transfected cellular extracts by immunoblot assays with
anti-GFP antibodies (Fig. 8). Sep15 was located in the mem-
branous reticular structures in the perinuclear region, when it
was transiently expressed in the form fused through its C-
terminal region to GFP (Fig. 7).
The N-terminal Signal Peptide of Sep15 Is Necessary for ER
Localization—Known ER resident proteins contain N-terminal
signal peptides that are required for translocation of proteins
into the ER. The signal peptide may be subsequently cleaved
from translocated proteins. As expected, Sep15 contained a
highly hydrophobic N-terminal signal peptide. We observed
previously that Sep15 isolated from a human T-cell line lacked
the N-terminal sequence (4), which is consistent with it being
an ER luminal protein.
To test a possible role of the N-terminal peptide, we devel-
oped a construct that encoded Sep15 located downstream of
GFP (the GFP-Sep15-C construct). This fusion protein, tran-
siently expressed in CV-1 cells, was distributed in a non-ER-
specific manner, including localization to the cytosol (Fig. 7).
Similar patterns were also observed in cells expressing a fusion
protein lacking the N-terminal peptide (Sep15-C-GFP) (Fig. 7).
Thus, removal of N-terminal sequences from the selenoprotein
resulted in a failure to direct Sep15 to the ER/Golgi domain,
suggesting an essential role of the N-terminal peptide in sel-
enoprotein translocation.
Sep15 Lacks an ER Retention Signal—ER resident proteins
generally contain a common C-terminal tetrapeptide, KDEL, or
very similar analogs. This tetrapeptide is necessary to prevent
ER resident proteins from exiting the ER cellular compart-
ment. However, the Sep15 sequence lacked such a signal and
instead terminated with LERI. To determine if the last four
residues of Sep15 constitute a novel ER retention signal or if
this selenoprotein is retained in the ER by another mechanism,
we developed a construct in which the GFP gene was inserted
between the N-terminal signal peptide and the rest of Sep15
(the N-GFP-Sep15-C construct). Such a design allowed the
GFP-Sep15 fusion protein to terminate on the natural C-ter-
minal sequence of Sep15 while containing the N-terminal sig-
FIG. 4. Copurification of Sep15 and UGTR in mouse liver frac-
tions. Elution of Sep15 and UGTR from a DEAE-HPLC column (A) and
from a phenyl-Superose column (B) is shown. Bars represent relative
75Se radioactivity of the 15-kDa protein determined with a Phosphor-
Imager, and bands represent immunoblot detection of UGTR with anti-
rat liver UGTR antibodies in the corresponding fractions. The phenyl-
Superose column did not resolve UGTR and the UGTRzSep15 complex.
FIG. 3. Immunoblot analyses of rat prostate Sep15 and UGTR.
Fractions containing hydrophobic proteins that eluted from a phenyl-
HPLC column were examined for the presence of Sep15 and UGTR by
Western blotting. Two fractions in which Sep15 and UGTR signals
peaked are shown in the figure. The first eluted fraction is shown in
lanes 1, 3, 5, and 7; and the second fraction is in lanes 2, 4, 6, and 8.
Immunoblot analysis with antibodies specific for Sep15 is shown in
lanes 1–4 and with antibodies specific for UGTR, in lanes 5–8. Lanes 1,
2, 5, and 6 correspond to reducing SDS-PAGE (in the presence of 10 mM
DTT), and lanes 3, 4, 7, and 8 correspond to nonreducing SDS-PAGE.
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nal peptide for ER translocation. In addition, a construct was
made which differed from the N-GFP-Sep15-C construct in that
it lacked the last four residues (N-GFP-Sep15; Fig. 6). Upon
transient expression in CV-1 cells, no differences were observed
between fusion proteins with and without the C-terminal pep-
tide, and both proteins were found residing in the ER/Golgi
structures (Fig. 7). Thus, the C-terminal sequence was not
important for intracellular trafficking and retention of Sep15.
To test further if the N-terminal signal peptide of Sep15 was
alone responsible for ER localization of the selenoprotein, we
expressed a GFP form containing N-terminal signal peptide of
Sep15 (N-GFP). This protein was detected in the ER and other
cellular compartments. Thus, the N-terminal signal was not
sufficient for exclusive ER localization of the protein. These
data suggested that the internal (without the N-terminal pep-
tide and the C-terminal tetrapeptide) selenoprotein sequence
was responsible for retention of the protein in the ER. It is
likely that the ER-translocated Sep15 is kept in this cellular
compartment through its tight interaction with UGTR, which
does have the C-terminal ER retention signal and the N-ter-
minal signal peptide.
To test whether the N-terminal single peptide was cleaved
from the fusion proteins upon translocation into the ER, we
calculated molecular masses for seven fusion products and for
their predicted forms obtained by cleavage of the N-terminal
signal peptide (Table I). These values were compared with
experimental masses obtained from immunoblot assays (Fig.
8). This experiment revealed that the signal peptide of Sep15
was cleaved in every case in which it was present as an N-
terminal sequence in a fusion protein, i.e. upstream of either
Sep15 or GFP. Indeed, immunoblot assays indicated similar
mobility of N-Sep15-GFP-C (Fig. 8, lanes 2 and 4) and Sep15-
GFP-C fusion proteins (Fig. 8, lane 3) on SDS-PAGE gels, as
well as similar mobility of GFP (Fig. 8, lane 1) and N-GFP (Fig.
8, lane 8). It should be noted that the proteins being compared
should have differed by 2.7 kDa if the N-terminal signal pep-
tide was retained. The difference of 2.7 kDa should be sufficient
to be resolved by our SDS-PAGE analysis because a difference
of 1.8 kDa was clearly seen when Sep15-C-GFP and GFP-
Sep15-C fusion proteins were compared (see Fig. 8, lanes 3 and
5, respectively).
DISCUSSION
In this report, we described the association between Sep15
and UGTR in the ER of mammalian cells. The data show that
Sep15 is tightly bound to UGTR, which suggests that this
selenoprotein may be linked to the quality control of protein
folding.
Sep15 had previously been isolated only from a human T-cell
line and only under denaturing conditions (4). Thus, a possi-
bility remained that Sep15 was a component of a multiprotein
complex or a homomultimer. Isolation of Sep15 from mamma-
lian tissues and cell lines was proven to be difficult because of
its extreme lability and low abundance. However, taking ad-
vantage of the finding that Sep15 exhibits high expression
levels in prostate (4), we isolated the protein from rat prostate.
A procedure for isolation of Sep15 was developed which com-
bined conventional chromatography and HPLC. This procedure
allowed rapid isolation of the protein and minimized losses
through denaturation.
FIG. 5. Immunoblot analyses of UGTR and Sep15 on native and SDS-PAGE gels. Mouse liver extracts were fractionated on Q-Sepharose,
ConA-Sepharose, phenyl-HPLC, and DEAE-HPLC columns as described under “Experimental Procedures.” Sep15 was detected during isolation by
the PhosphorImager and immunoblot assays and UGTR, by immunoblot assays. Late eluting fractions from a phenyl column were electrophoresed,
transblotted, and blots were probed with antibodies specific for Sep15 or UGTR. A, analysis with antibodies specific for UGTR on a nondenaturing
(native) PAGE gel. B, analysis with antibodies specific for UGTR on a SDS-PAGE gel. C, analysis with antibodies specific for Sep15 on a native
PAGE gel. D, analysis with antibodies specific for Sep15 on a SDS-PAGE gel. E, Coomassie Blue staining of the native gel.
FIG. 6. Schematic representation of
selenoprotein-GFP fusion con-
structs. Sep15-GFP fusion constructs
were developed to determine the intracel-
lular localization of the 15-kDa protein.
Construct, Fusion protein, and Localiza-
tion in the figure show (i) the specific con-
struct, (ii) the organization of the fused
protein, where N designates the 28-resi-
due N-terminal signal peptide of Sep15;
Sep15, the 15-kDa selenoprotein without
its signal peptide and its four C-terminal
residues; C, the 4 C-terminal residues of
Sep15; and GFP, a 239-residue GFP; and
(iii) polypeptides localized in the ER, re-
spectively. For details, see “Results.”
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The isolated selenoprotein was found to occur in a complex
with a 150-kDa protein. Comparison of sequenced peptides
from the 150-kDa protein with the deduced sequence of rat
liver UGTR revealed 100% identity in four peptide sequences.
Western blot analyses of the 150-kDa protein with the anti-
UGTR antibodies, as well as analyses of fractionated mouse
liver extracts, further supported the conclusion that Sep15 was
purified in a complex with UGTR. This finding was unexpected
for the following reasons. (i) UGTR is known for its role in the
quality control of protein folding (6). This enzyme recognizes
misfolded protein domains in the ER lumen of eukaryotic cells
and specifically glucosylates these proteins, which retains mis-
folded proteins in the ER for the next cycle of folding by the
calnexin/calreticulin glycoprotein folding system (15, 16, 21).
Previously characterized eukaryotic selenoproteins were in-
volved in redox processes (2), and redox function has been
anticipated for Sep15, but the quality control of protein folding
has not been linked to a redox process. (ii) UGTR is located in
the ER (17), and no selenoprotein has yet been found to occur in
this cellular compartment. In addition to Sep15, two other
known mammalian selenoproteins, glutathione peroxidase 3
and selenoprotein P, contain N-terminal signal peptides. These
proteins are secreted and are the major selenoproteins in the
plasma of mammals (22). Most other known mammalian sel-
enoproteins are cytosolic, nuclear, or mitochondrial proteins.
To determine the intracellular localization of Sep15, we
made a series of constructs that encoded fusion proteins be-
tween Sep15 and GFP. In addition, we tested the relevance of
the N-terminal portion of Sep15 for the ER translocation and of
the C-terminal portion of the protein for ER retention. Expres-
sion patterns of the GFP fusion constructs containing Sep15
sequences in CV-1 cells were examined and compared with
location of a marker by live-cell imaging confocal microscopy.
Although the marker that was used in the present study is
known to label both ER and Golgi, the fact that UGTR is the ER
resident protein strongly suggests that Sep15 colocalized with
UGTR in the ER. The data from imaging analyses in combina-
tion with other biochemical evidence demonstrated that the
N-terminal signal peptide of Sep15 was necessary for ER local-
ization. In contrast, the C-terminal tetrapeptide of the seleno-
protein lacked a typical ER retention signal, and this sequence
was not necessary to keep the protein in the ER. It appears that
the selenoprotein sequence itself was responsible for retaining
Sep15 in the ER and preventing its secretion. The data thus
suggested that Sep15 was maintained in the ER because of its
interaction with UGTR.
FIG. 7. Confocal microscopy. Confocal images of CV-1 cells ex-
pressing various GFP-tagged Sep15 and control proteins are shown. A
set of three images is shown for each construct. Left panels show green
fluorescence corresponding to transiently expressed fusion proteins.
Center panels show fluorescence of the ER/Golgi marker. Right panels
show images obtained by merging left and center panels. The scale bar
is 100 mm. The GFP fusion constructs used in this experiment are
shown on the left.
FIG. 8. Immunoblot detection of the GFP-Sep15 fusion pro-
teins. CV-1 cells were transiently transfected with plasmids encoding
GFP (lane 1), N-Sep15-C-GFP (lanes 2 and 4; two independent trans-
fection experiments are shown), Sep15-C-GFP (lane 3), GFP-Sep15-C
(lane 5), N-GFP-Sep15-C (lane 6), N-GFP-Sep15 (lane 7), and N-GFP
(lane 8) as described under “Experimental Procedures.” Samples were
probed with antibodies specific for GFP.
TABLE I
Characteristics of Sep15-GFP constructs
The design of the constructs is described under “Experimental Pro-
cedures.”
Constructa and
compositionb
Predicted molecular
massc
Predicted molecular mass
(N terminus is cleaved)d
kDa kDa
N-Sep15-C-GFP
161-aa Sep15 47.0 44.3
22-aa linker
239-aa GFP
Sep15-C-GFP
136-aa Sep15 44.6 44.6
22-aa linker
239-aa GFP
GFP-Sep15-C
239-aa GFP 42.8 42.8
6-aa linker
136-aa Sep15
N-GFP-Sep15-C
37-aa N-terminal 46.9 44.1
4-aa linker
239-aa GFP
6-aa linker
136-aa Sep15
N-GFP-Sep15
37-aa N-terminal 46.3 43.6
4-aa linker
239-aa GFP
6-aa linker
132-aa Sep15
N-GFP
37-aa N-terminal 30.9 28.2
4-aa linker
239-aa GFP
GFP
239-aa GFP 26.9 26.9
a Sep15 is a protein without its 28 N-terminal and its 4 C-terminal
residues; N is the N-terminal signal peptide of Sep15; and C represents
four C-terminal residues of Sep15.
b Composition reflects sizes of Sep15 fragments, linkers, and GFP
shown in numbers of amino acids (aa).
c Molecular masses were calculated for full-length proteins expressed
from constructs.
d Molecular masses were calculated for proteins in which the N-
terminal signal peptide of Sep15 was cleaved between Ala28 and Phe29.
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The binding between Sep15 and UGTR appeared to be very
strong because these proteins copurified at each isolation step.
Moreover, Sep15 was found exclusively in the UGTR-bound
form. The lack of the UGTR-free selenoprotein may also be
consistent with the idea that Sep15 and UGTR are subunits of
a two-subunit protein. It is possible that the presence of the
selenoprotein subunit in UGTR preparations was unnoticed
previously because of the small size of Sep15, which made it
difficult to visualize the selenoprotein by protein staining on
SDS-PAGE gels. In addition, low percentage SDS-PAGE gels
have been used previously for homogeneity assessment of iso-
lated UGTR (8). In these gels, selenoprotein would migrate in
the dye front.
In contrast to the exclusive binding of Sep15 to UGTR, the
latter protein was detected in both selenoprotein-bound and sel-
enoprotein-free forms. It remains to be determined if the seleno-
protein-free form arose by the release of the denatured seleno-
protein during protein isolation, if it was a natural UGTR form or
if UGTR also occurred in a complex with other proteins and/or
selenoproteins.
UGTR was shown previously, by immunoprecipitation, to
associate with misfolded proteins, such as a1-antitrypsin (23),
and with other ER resident proteins, such as protein disulfide
isomerases, carboxylesterase, and the glucose-regulated pro-
tein (24). However, these proteins do not copurify with UGTR,
and only a small fraction of them was associated with this
enzyme. Sep15, on the other hand, was found exclusively in the
UGTR-bound form in rat prostate and mouse liver.
UGTR is the only known quality control protein that recog-
nizes misfolded proteins in the ER, and its mechanism has
been characterized in great detail. Interestingly, UGTR is able
to glucosylate misfolded domains specifically while not reacting
with properly folded domains within a protein composed of
identical folded and misfolded domains (16).
The possible role of redox processes in the ER-based protein
folding has received much attention recently. In particular,
protein disulfide isomerase was found to remove electrons,
through the disulfide bond formation, from folding proteins and
to transfer reducing equivalents further to the ER membrane
protein Ero1 (25, 26). The formation of disulfide bonds in nas-
cent polypeptides is believed to be associated with folding by
the calnexin/calreticulin chaperones. Although properly folded
proteins may proceed further to secretory pathways, misfolded
polypeptides including those containing disulfide bonds are
glucosylated by UGTR to retain them for the next cycle of
folding. Sensing or reduction of disulfides within misfolded
proteins prior to folding appears to be required. Whether Sep15
is involved in such redox reactions is a direction for further
research.
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